Mesna and Camptosar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mesna (mesna) and Camptosar (irinotecan hydrochloride). Common drug interactions include fatigue among females and stomatitis among males.

The phase IV clinical study analyzes what interactions people have when they take Mesna and Camptosar. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Mesna?

Mesna has active ingredients of mesna. eHealthMe is studying from 9,647 Mesna users. Check the latest studies of Mesna.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

21 people who take Mesna and Camptosar together, and have interactions are studied.

What are the common drug interactions of Mesna and Camptosar, by gender? *:

female:

Fatigue (feeling of tiredness)
Back pain
Death
Malignant neoplasm progression (cancer tumour came back)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Vision blurred

male:

Stomatitis (inflammation of mucous membrane of mouth)
Pharyngeal inflammation
Malignant neoplasm progression (cancer tumour came back)
Metastases to meninges (cancer spreads to meninges)
Nystagmus (a condition of involuntary eye movement)
Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pyrexia (fever)
Respiratory distress (difficulty in breathing)
Respiratory rate decreased (less breathing rate/min)

What are the common drug interactions of Mesna and Camptosar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Vomiting
Abdominal distension
Abdominal pain
Angioedema (rapid swelling of the dermis)
Atelectasis (partial or complete collapse of the lung)
Coagulopathy (blood's ability to clot is impaired)
Decreased appetite

10-19:

Stomatitis (inflammation of mucous membrane of mouth)
Pharyngeal inflammation
Dry mouth
Hypophagia (reduced food intake)
Neutropenia (an abnormally low number of neutrophils)
Oral pain
Oropharyngeal pain

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 8 people, 38.10%
Pain: 2 people, 9.52%
Nausea (feeling of having an urge to vomit): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Mesna and Camptosar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously